The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors

Citation
R. Hromas et al., The Exodus subfamily of CC chemokines inhibits the proliferation of chronic myelogenous leukemia progenitors, BLOOD, 95(4), 2000, pp. 1506-1508
Citations number
21
Categorie Soggetti
Hematology,"Cardiovascular & Hematology Research
Journal title
BLOOD
ISSN journal
00064971 → ACNP
Volume
95
Issue
4
Year of publication
2000
Pages
1506 - 1508
Database
ISI
SICI code
0006-4971(20000215)95:4<1506:TESOCC>2.0.ZU;2-R
Abstract
Chemokines are a family of related proteins that regulate leukocyte infiltr ation into inflamed tissue and play important roles in disease processes. A mong the biologic activities of chemokines is inhibition of proliferation o f normal hematopoietic progenitors. However, chemokines that inhibit normal progenitors rarely inhibit proliferation of hematopoietic progenitors from patients with chronic myelogenous leukemia (CML). We and others recently c loned a subfamily of CC chemokines that share similar aminoterminal peptide sequences and a remarkable ability to chemoattract T cells. These chemokin es, Exodus-1/LARC/MIP-3 alpha, Exodus-2/SLC/6Ckine/TCA4, and Exodus-3/CK be ta 11/MIP-3 beta, were found to inhibit proliferation of normal human marro w progenitors. The study described here found that these chemokines also in hibited the proliferation of progenitors in every sample of marrow from pat ients with CML that was tested. This demonstration of consistent inhibition of CML progenitor proliferation makes the 3 Exodus chemokines unique among chemokines. (C) 2000 by The American Society ct Hematology.